These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 27932582)
1. Safety immunopharmacology: evaluation of the adverse potential of pharmaceuticals on the immune system. Descotes J J Pharmacol Toxicol Methods; 2012 Sep; 66(2):79-83. PubMed ID: 22587937 [TBL] [Abstract][Full Text] [Related]
2. Justification for species selection for pharmaceutical toxicity studies. Prior H; Haworth R; Labram B; Roberts R; Wolfreys A; Sewell F Toxicol Res (Camb); 2020 Dec; 9(6):758-770. PubMed ID: 33442468 [TBL] [Abstract][Full Text] [Related]
3. Data science in drug discovery safety: Challenges and opportunities. Coltman NJ; Roberts RA; Sidaway JE Exp Biol Med (Maywood); 2023 Nov; 248(21):1993-2000. PubMed ID: 38062553 [TBL] [Abstract][Full Text] [Related]
5. Genetically Defined Strains in Drug Development and Toxicity Testing. Festing MF Methods Mol Biol; 2016; 1438():1-17. PubMed ID: 27150081 [TBL] [Abstract][Full Text] [Related]
6. Toxicology testing in drug discovery and development. Dorato MA; Buckley LA Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.1. PubMed ID: 23045141 [TBL] [Abstract][Full Text] [Related]
7. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals. van Meer PJ; Graham ML; Schuurman HJ Eur J Pharmacol; 2015 Jul; 759():3-13. PubMed ID: 25818943 [TBL] [Abstract][Full Text] [Related]
9. Impact of the Genetics and Source of Preclinical Safety Animal Models on Study Design, Results, and Interpretation. Colman K Toxicol Pathol; 2017 Jan; 45(1):94-106. PubMed ID: 27753639 [TBL] [Abstract][Full Text] [Related]
10. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products. Cavagnaro J; Silva Lima B Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257 [TBL] [Abstract][Full Text] [Related]